Alpha Cognition (ACOG) Competitors $10.47 -0.22 (-2.06%) As of 07/3/2025 01:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock ACOG vs. XNCR, SAGE, KALV, DNTH, RLAY, IOVA, AMLX, DNA, ARVN, and KROSShould you be buying Alpha Cognition stock or one of its competitors? The main competitors of Alpha Cognition include Xencor (XNCR), Sage Therapeutics (SAGE), KalVista Pharmaceuticals (KALV), Dianthus Therapeutics (DNTH), Relay Therapeutics (RLAY), Iovance Biotherapeutics (IOVA), Amylyx Pharmaceuticals (AMLX), Ginkgo Bioworks (DNA), Arvinas (ARVN), and Keros Therapeutics (KROS). These companies are all part of the "pharmaceutical products" industry. Alpha Cognition vs. Its Competitors Xencor Sage Therapeutics KalVista Pharmaceuticals Dianthus Therapeutics Relay Therapeutics Iovance Biotherapeutics Amylyx Pharmaceuticals Ginkgo Bioworks Arvinas Keros Therapeutics Alpha Cognition (NASDAQ:ACOG) and Xencor (NASDAQ:XNCR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership, media sentiment and analyst recommendations. Is ACOG or XNCR more profitable? Alpha Cognition has a net margin of 0.00% compared to Xencor's net margin of -181.17%. Xencor's return on equity of -31.94% beat Alpha Cognition's return on equity.Company Net Margins Return on Equity Return on Assets Alpha CognitionN/A -65.83% -48.21% Xencor -181.17%-31.94%-22.19% Which has stronger earnings and valuation, ACOG or XNCR? Alpha Cognition has higher earnings, but lower revenue than Xencor. Alpha Cognition is trading at a lower price-to-earnings ratio than Xencor, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha CognitionN/AN/A-$14.64M-$1.20-8.73Xencor$110.49M5.41-$232.62M-$3.06-2.75 Do analysts rate ACOG or XNCR? Alpha Cognition presently has a consensus price target of $20.00, indicating a potential upside of 91.02%. Xencor has a consensus price target of $28.00, indicating a potential upside of 233.14%. Given Xencor's higher probable upside, analysts clearly believe Xencor is more favorable than Alpha Cognition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Cognition 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Xencor 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media favor ACOG or XNCR? In the previous week, Alpha Cognition had 2 more articles in the media than Xencor. MarketBeat recorded 4 mentions for Alpha Cognition and 2 mentions for Xencor. Xencor's average media sentiment score of 0.51 beat Alpha Cognition's score of 0.35 indicating that Xencor is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Cognition 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Xencor 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, ACOG or XNCR? Alpha Cognition has a beta of 2.73, meaning that its share price is 173% more volatile than the S&P 500. Comparatively, Xencor has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. SummaryXencor beats Alpha Cognition on 7 of the 13 factors compared between the two stocks. Get Alpha Cognition News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACOG vs. The Competition Export to ExcelMetricAlpha CognitionMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$167.65M$2.91B$5.54B$9.05BDividend YieldN/A2.44%5.24%4.02%P/E Ratio-8.7221.5627.4320.22Price / SalesN/A281.76416.87118.64Price / CashN/A42.7336.8958.07Price / Book4.047.518.035.67Net Income-$14.64M-$55.05M$3.18B$249.13M7 Day Performance15.05%4.61%2.88%3.28%1 Month Performance8.27%4.72%3.69%5.56%1 Year PerformanceN/A5.92%36.02%21.12% Alpha Cognition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACOGAlpha Cognition1.7696 of 5 stars$10.47-2.1%$20.00+91.0%N/A$167.65MN/A-8.72N/ANews CoverageXNCRXencor4.0329 of 5 stars$7.86-3.4%$28.00+256.2%-54.8%$579.33M$110.49M-2.57280Positive NewsSAGESage Therapeutics3.2437 of 5 stars$9.12-0.3%$8.93-2.0%-13.4%$572.98M$41.24M-1.57690High Trading VolumeKALVKalVista Pharmaceuticals4.1757 of 5 stars$11.31-0.9%$24.83+119.6%+1.5%$567.26MN/A-3.04100Upcoming EarningsDNTHDianthus Therapeutics1.6041 of 5 stars$18.63+5.7%$53.00+184.5%-27.7%$566.98M$6.24M-6.4780News CoverageAnalyst ForecastAnalyst RevisionRLAYRelay Therapeutics2.1408 of 5 stars$3.46+4.8%$17.67+410.6%-42.3%$565.77M$10.01M-1.55330Positive NewsIOVAIovance Biotherapeutics4.709 of 5 stars$1.72+1.8%$12.22+610.6%-76.3%$564.35M$164.07M-1.39500AMLXAmylyx Pharmaceuticals3.5169 of 5 stars$6.41+1.3%$11.00+71.6%+255.9%$564.26M$87.37M-2.06200DNAGinkgo Bioworks1.1292 of 5 stars$11.29+19.3%$5.77-48.9%N/A$553.71M$227.04M-1.23640Gap UpARVNArvinas3.1189 of 5 stars$7.36-2.4%$20.29+175.7%-67.0%$550.35M$426.90M-11.15420KROSKeros Therapeutics3.6204 of 5 stars$13.35-1.0%$30.56+128.9%-68.4%$547.90M$3.55M-74.17100 Related Companies and Tools Related Companies XNCR Competitors SAGE Competitors KALV Competitors DNTH Competitors RLAY Competitors IOVA Competitors AMLX Competitors DNA Competitors ARVN Competitors KROS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACOG) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Cognition Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Cognition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
